Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells

被引:55
作者
Plano, Daniel [1 ]
Sanmartin, Carmen [1 ]
Moreno, Esther [1 ]
Prior, Celia [2 ]
Calvo, Alfonso [2 ]
Palop, Juan Antonio [1 ]
机构
[1] Univ Navarra, Dept Quim Organ & Farmaceut, Secc Sintesis, E-31008 Pamplona, Spain
[2] Univ Navarra, CIMA, Ctr Appl Med Res, Div Oncol, E-31008 Pamplona, Spain
关键词
organoselenium; cytotoxics; prostate;
D O I
10.1016/j.bmcl.2007.10.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 17 symmetrical substituted imidothiocarbamate and imidoselenocarbamate derivatives has been synthesized by reacting appropriately substituted acyl chlorides with alkyl imidothiocarbamates and alkyl imidoselenocarbamates. The antitumoral activities of the compounds were evaluated in vitro by examining their cytotoxic effects against human prostate cancer cells (PC-3). Five compounds showed interesting activity levels and 3p (IC50 = 1.85 mu M) was 7.3 times more active than the standard etoposide used in the treatment of prostate cancer and emerges as the most interesting compound. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6853 / 6859
页数:7
相关论文
共 50 条
  • [31] Aldol derivatives of Thioxoimidazolidinones as potential anti-prostate cancer agents
    Khatik, Gopal L.
    Kaur, Jasmine
    Kumar, Varun
    Tikoo, Kulbhushan
    Venugopalan, P.
    Nair, Vipin A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (08) : 3291 - 3301
  • [32] Cytotoxic effects of ultra-diluted remedies on breast cancer cells
    Frenkel, Moshe
    Mishra, Bal Mukund
    Sen, Subrata
    Yang, Peiying
    Pawlus, Alison
    Vence, Luis
    Leblanc, Aimee
    Cohen, Lorenzo
    Banerji, Pratip
    Banerji, Prasanta
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (02) : 395 - 403
  • [33] Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells
    McPherson, R. A. C.
    Galettis, P. T.
    de Souza, P. L.
    BRITISH JOURNAL OF CANCER, 2009, 100 (04) : 649 - 655
  • [34] Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting
    Pejcic, Tomislav
    Todorovic, Zoran
    Durasevic, Sinisa
    Popovic, Lazar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [35] Transport of methotrexate into LNCaP human prostate cancer cells
    Horne, DW
    Reed, KA
    BIOFACTORS, 2002, 16 (1-2) : 19 - 27
  • [36] The role of stromal cells in prostate cancer development and progression
    Condon, MS
    Bosland, MC
    IN VIVO, 1999, 13 (01): : 61 - 65
  • [37] Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells
    R A C McPherson
    P T Galettis
    P L de Souza
    British Journal of Cancer, 2009, 100 : 649 - 655
  • [38] Regulated expression of diphtheria toxin in prostate cancer cells
    Peng, WD
    Verbitsky, A
    Bao, YH
    Sawicki, JA
    MOLECULAR THERAPY, 2002, 6 (04) : 537 - 545
  • [39] Prostate cancer stem cells: Are they androgen-responsive?
    Oldridge, Emma E.
    Pellacani, Davide
    Collins, Anne T.
    Maitland, Norman J.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 14 - 24
  • [40] A novel murine model of allogeneic vaccination against prostate cancer
    Labarthe, M. -C.
    Theocharous, P.
    Russell, N.
    Todryk, S.
    Bangma, C.
    Thraves, P.
    Dalgleish, A. G.
    Whelan, M. A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (04) : 453 - 465